"Hep G2 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A human liver tumor cell line used to study a variety of liver-specific metabolic functions.
| Descriptor ID |
D056945
|
| MeSH Number(s) |
A11.251.860.180.432 A11.436.348.500
|
| Concept/Terms |
Hep G2 Cells- Hep G2 Cells
- Cell, Hep G2
- Cells, Hep G2
- Hep G2 Cell
- HepG2 Cells
- Cell, HepG2
- Cells, HepG2
- HepG2 Cell
- Hep G2 Cell Line
- Hepatoblastoma G2 Cell Line
- Cell Line, Hep G2
- Cell Line, Hepatoblastoma G2
|
Below are MeSH descriptors whose meaning is more general than "Hep G2 Cells".
Below are MeSH descriptors whose meaning is more specific than "Hep G2 Cells".
This graph shows the total number of publications written about "Hep G2 Cells" by people in this website by year, and whether "Hep G2 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 90 | 90 |
| 2018 | 0 | 93 | 93 |
| 2019 | 0 | 33 | 33 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hep G2 Cells" by people in Profiles.
-
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response. Signal Transduct Target Ther. 2021 09 01; 6(1):331.
-
Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal. Sci Rep. 2021 08 17; 11(1):16629.
-
CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro. Front Immunol. 2021; 12:652223.
-
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2. Cells. 2021 06 08; 10(6).
-
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction. Biochem Pharmacol. 2021 06; 188:114564.
-
Translational adaptation of human viruses to the tissues they infect. Cell Rep. 2021 03 16; 34(11):108872.
-
Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein. EMBO Mol Med. 2021 03 05; 13(3):e13549.
-
A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2. Angew Chem Int Ed Engl. 2021 03 15; 60(12):6799-6806.
-
Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein. Theranostics. 2021; 11(2):649-664.
-
CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target. SLAS Discov. 2021 03; 26(3):336-344.